News

People coming off obesity jabs like Wegovy and Mounjaro should have check-ups for at least a year to make sure they don't ...
At least 26 patients have filed lawsuits in Marion County against Eli Lilly and Co. over its marketing of GLP-1 drugs ...
Patients coming off weight loss jabs need support and advice for at least a year to ensure lasting benefit from the drugs, the UK’s medicine watchdog has said. An estimated four in five patients who ...
Doctors at ZAVA warned that these summer staples can cause your blood sugar levels to crash and dehydrate you. This effect ...
Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...
Around 240,000 people are expected to be offered Mounjaro over the next three years, according to NICE, which has recommended ...
Research shows that many people regain weight after stopping treatment if they are not supported. Health chiefs have raised concerns about people regaining weight after using Wegovy and Mounjaro, ...
Health chiefs have raised concerns about patients regaining weight after stopping popular weight-loss drugs such as Wegovy ...
Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...
Swiss generic drug manufacturer Sandoz plans to launch unbranded weight-loss drugs in Canada at discounts of up to 70% compared to branded versions once patents begin to expire next year, CEO Richard ...
Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.
Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...